The University of Stellenbosch

Publications during 2020

Despite the various challenges brought on during 2020, the DTTC continued to contribute to publications on various academic platforms.

Research outputs–peer-reviewed scientific publications 2020

Manuscripts

Desmond Tutu TB Centre publications

  1. Ahmed S, Mvalo T, Akech S, Agweyu A, Baker K, Bar-Zeev,N, … Hesseling AC … Seddon JA, … van der Zalm M …. and Cunningham S. 2020. Protecting children in low-income and middle-income countries from COVID-19. BMJ Global Health, 5(5). PMID: 32461228. PMCID: PMC7254117.
  2. Allwood, B.W., Byrne, A., Meghji, J., Rachow, A., van der Zalm, M.M. and Schoch, O.D., Post-Tuberculosis Lung Disease: Clinical Review of an Under-Recognised Global Challenge. Respiration, pp.1-13. PMID: 33401266
  3. Allwood BW, Van der Zalm MM, Amaral AFS, Byrne A, Datta, S, Egere U, Evans CA, Evans D, Gray DM, Hoddinott G, Ivanova O, Jones R, Makanda G, Marx FM, Meghji J, Mpagama S, Pasipanodya JG, Rachow A, Schoeman I, Shaw J, Stek C, Van Kampen S, von Delft D, Walker NF, Wallis RS, Mortimer K. Post-tuberculosis lung health: perspectives from the First International Symposium. INT J TUBERC LUNG DIS 24(8):820–828 Q 2020 The Union.
  4. Battista Migliori G, Tiberi S, Zumla A, Petersen E, Muhwa Chakaya J, Wejse C, Muñoz Torrico M, Duarte R, Alffenaar JW, Schaaf HS, Marais BJ. MDR/XDR-TB management of patients and contacts: challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network. Int J Infect Dis. 2020; 92S:S15-S25. PMID:32032752
  5. Bekken GK, Ritz C, Selvam S, Jesuraj N, Hesseling AC, Doherty TM, Grewal HMS, Vaz M, Jenum S. Identification of subclinical tuberculosis in household contacts using exposure scores and contact investigations. BMC Infect Dis. 2020 Jan 31;20(1):96. PMID: 2005136.
  6. Boyles TH, Lynen L, Seddon JA; Tuberculous Meningitis International Research Consortium.Decision-making in the diagnosis of tuberculous meningitis. Wellcome Open Res. 2020; 5: 11
  7. Carreras-Abad C, Espiau M, López-Seguer L, Martín-Begué N, Martín-Nalda A, Melendo-Pérez S, Mendoza-Palomar N, Soler-Palacin P, Schaaf HS, Soriano-Arandes A. Adverse events associated with new injectable-free multidrug-resistant tuberculosis drug regimens. Arch Bronconeumol 2020 Aug 12;S0300-2896(20)30231-3. PMID: 32800388.
  8. Chiang SS, Park S, White EI, Friedman JF, Cruz AT, Del Castillo H, Lecca L, Becerra MC, Seddon JA. Using Changes in Weight-for-Age z Score to Predict Effectiveness of Childhood Tuberculosis Therapy. J Pediatric Infect Dis Soc. 2020; 9: 150-158
  9. Chiang SS, Brooks MB, Jenkins HE, Rubenstein D, Seddon JA, van der Water B, Lindeborg M, Becerra M, Yuen C. Concordance of drug resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis. Clin Infect Dis. 2020. PMID: 32448887.
  10. Cox V, McKenna L, Acquah R, Reuter A, Wasserman S, Vambe D, Ustero P, Udwadia Z, Triviño-Duran L, Tommasi M, Skrahina A, Seddon JA, Rodolfo R, Rich M, Padinalam X, Oyewusi L, Ohler L, Lungu P, Loveday M, Khan U, Khan P, Hughes J, Hewison C, Guglielmetti L, Furin J. Clinical Perspectives on Treatment of Rifampicin-Resistant/Multidrug-Resistant Tuberculosis. Int J Tuberc Lung Dis 2020. PMID: 33172520.
  11. de Villiers L, Thomas A, Jivan D, Hoddinott G, Hargreaves JR, Bond V, Stangl A, Bock P, Reynolds L. Stigma and HIV service access among transfeminine and gender diverse women in South Africa–a narrative analysis of longitudinal qualitative data from the HPTN 071 (PopART) trial. BMC public health. 2020 Dec;20(1):1-3.
  12. Dodd P, Yuen C, Jayasooriya S, van der Zalm M, Seddon J. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infectious Diseases. 2020 Nov 16.
  13. Donald PR, Ronge L, Demers AM, Thee S, Schaaf HS, Hesseling AC.Positive Mycobacterium tuberculosis Gastric Lavage Cultures from Asymptomatic Children with Normal Chest Radiography. J Pediatric Infect Dis Soc. 2020 Oct 20:piaa113. doi: 10.1093/jpids/piaa113. Online ahead of print.PMID: 33079203
  14. du Preez K, Schaaf HS, Dunbar R, Swartz A, Naidoo P, Hesseling AC. Closing the reporting gap for childhood tuberculosis in South Africa: improving hospital referrals and linkages. Public Health Action (PHA) 2020; 10(1):38-46. PMID: 32368523.
  15. du Preez K, Seddon JA, Schaaf HS, Hesseling AC. Where are we in the battle of ending tuberculosis in children and adolescents in South Africa? S Afr Med J. Published online 26 March 2020. PMID: 32657712.
  16. Eshleman SH, Piwowar-Manning E, Wilson EA, Lennon D, Fogel JM, Agyei Y, Sullivan PA, Weng L, Moore A, Laeyendecker O, Kosloff B, Bwalya J, Maarman G, van Deventer A, Floyd S, Bock P, Ayles H, Fidler S, Hayes R, Donnell D; HPTN 071 (PopART) Study Team. Determination of HIV status and identification of incident HIV infections in a large, community-randomized trial: HPTN 071 (PopART). J Int AIDS Soc. 2020 Feb;23(2):e25452. PMID:32072743.
  17. Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, van Zyl G, Grobbelaar N, Ayles H, Hayes R, Beyers N, Fidler S. Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts≥ 500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa. Clinical Infectious Diseases. 2020 Jan 16;70(3):395-403. PMID: 30877753.
  18. Fernández-Luis S, Nhampossa T, Fuente-Soro L, Augusto O, Casellas A, Bernardo E, Ruperez M, Gonzalez R, Maculuve S, Saura-Lázaro A, Menendez C, Naniche D, Lopez-Varela E. Pediatric HIV Care Cascade in Southern Mozambique: Missed Opportunities for Early ART and Re-engagement in Care. The Pediatric Infectious Disease Journal. 2020 Feb 28. PMID: 32091497.
  19. Floyd S, Shanaube K, Yang B, Schaap A, Griffith S, Phiri M, Macleod D, Sloot R, Sabapathy K, Bond V, Bock P. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial. PLoS medicine. 2020 Apr 2;17(4):e1003067. PMID: 32240156.
  20. Ganmaa D, Uyanga B, Zhou X, Gantsetseg G, Delgerekh B, Enkhmaa D, Khulan D, Ariunzaya S, Sumiya E, Bolortuya B, Yanjmaa J, Enkhtsetseg T, Munkhzaya A, Tunsay M, Khudyakov P, Seddon JA, Marais BJ, Batbayar O, Erdenetuya G Amarsaikhan B, Spiegelman D, Tsolmon J, Martineau AR. Vitamin D Supplementation to Prevent Tuberculosis Infection and Disease. New England Journal of Medicine. 2020 Jul 23;383(4):359-68. PMID: 32706534
  21. Garcia-Prats AJ, Salazar-Austin N, Conway JH, Radtke K, LaCourse SM,

Maleche-Obimbo E,  Hesseling AC, Savic RM, Nachman S. COVID-19 pharmacologic treatments for children: research priorities and approach to paediatric studies. Clin Infect Dis. 2020 Jun 29:ciaa885. doi: 10.1093/cid/ciaa885. PMID: 32594142

  1. Gausi K, Wiesner L, Norman J, Wallis CL, Onyango-Makumbi C, Chipato T, Haas DW, Browning R, Chakhtoura N, Montepiedra G, Aaron L, McCarthy K, Bradford S, Vhembo T, Stranix-Chibanda L, Masheto GR, Violari A, Mmbaga BT, Aurpibul L, Bhosale R, Nevrekhar N, Rouzier V, Kabugho E, Mutambanengwe M, Chanaiwa V, Nyati M, Mhembere T, Tongprasert F, Hesseling A, Shin K, Zimmer B, Costello D, Jean- Philippe P, Sterling TR, Theron G, Weinberg A, Gupta A, Denti P. P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and drug-drug interactions of isoniazid and efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping. Clin Pharmacol Ther. 2020 Sep 9. doi: 10.1002/cpt.2044. Epub ahead of print. PMID: 32909316.
  2. Goussard P, Van Wyk L, Burke J, Malherbe A, Retief F, Andronikou S, Mfingwana L, Ruttens D, Van Zalm MM, Dramowski A, Da Costa A, Rabie H. “Bronchoscopy in children with COVID-19: A case series” Pediatr Pulmonol. 2020 Aug 7:10.1002/ppul.25015. doi: 10.1002/ppul.25015. [Online ahead of print.] PMID: 32767742
  3. Gröschel MI, Seddon JA, Prabowo SA, Migliori GB, Graham SM, van den Boom M, Dara M. European guidance on drug-resistant tuberculosis in children and adolescents. Lancet Child Adolesc Health. 2020; 4: 9-11
  4. Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, Dawson R, Mave V, Sanchez J, Mendoza A, Gonzales P, … Garcia-Prats A, … Hesseling AC. Feasibility of identifying household contacts of rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clinical Infectious Diseases. 2020 Jan 16;70(3):425-35. PMID: 30942853.
  5. Hargreaves JR, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D, Piwowar-Manning E, Agyei Y, Mandla NF, Dunbar R, Macleod D. HIV Stigma and viral suppression among people living with HIV in the context of Universal Test and Treat: Analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa. Journal of acquired immune deficiency syndromes (1999). 2020 Dec 15;85(5):561. PMID: 32991336.
  6. Hirsch-Moverman Y, Mantell JE, Lebelo L, Howard AA, Hesseling AC, Nachman, S., Frederix K, Maama LB, El-Sadr WM. Provider Attitudes About Childhood Tuberculosis Prevention in Lesotho: A Qualitative Study. BMC Health Serv Res. 2020 May 25;20(1):461. doi: 10.1186/s12913-020-05324-0. PMID: 32450858.
  7. Huynh J, Thwaites G, Marais BJ, Schaaf HS. Tuberculosis treatment in children: the changing landscape. Paediatric Respiratory Reviews. 2020 Feb 26. PMID: 32241748.
  8. Jones HS, Floyd S, Stangl A, Bond V, Hoddinott G, Pliakas T, Bwalya J, Mandla N, Moore A, Donnell D, Bock P, Fidler S, Hayes R, Ayles H, Hargreaves JR, on behalf of the HPTN 071 (PopART) study team. Association between HIV‐stigma and antiretroviral therapy adherence among adults living with HIV: Baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa. Trop Med Int Health;tmi.13473. PMID: 32745296
  9. Krishnaratne S, Bond V, Stangl A, Pliakas T, Mathema H, Lilleston P, Hoddinott

G, Bock P, Ayles H, Fidler S, Hargreaves JR. Stigma and Judgment Toward People

Living with HIV and Key Population Groups Among Three Cadres of Health Workers in South Africa and Zambia: Analysis of Data from the HPTN 071 (PopART) Trial. AIDS Patient Care STDS. 2020 Jan;34(1):38-50. doi: 10.1089/apc.2019.0131. PMID: 31944852

  1. Lishman J, Kohler C, de Vos C, van der Zalm MM, Itana J, Redfern A, Smit L, Rabie H. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19. Pediatr. Infect. Dis. J. 2020 Sep 7. [Online ahead of print.] PMID: 32925543
  2. Loveday M, Hughes J, Sunkari VB, Master I, Chotoo S, Hlangu S, Green N, Seddon JA. Maternal and infant outcomes in pregnant women treated for rifampicin-resistant tuberculosis in KwaZulu-Natal, South Africa. Clin Infect Dis 2020. PMID: 32141495.
  3. Mandalakas AM, Hesseling AC, Kay A, Du Preez K, Martinez L, Ronge L, DiNardo A, Lange C, Kirchner HL. Tuberculosis prevention in children: A prospective community based study in South Africa. European Respiratory Journal. 2020 Jan. PMID: 33122339.
  4. Marx FM, Cohen T, Menzies NA, Salomon JA, Theron G, Yaesoubi R. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting: a model-based analysis. Lancet Glob Health. 2020 Sep;8(9):e1223-e1233. PMID: 32827484.
  5. Marx M. Cost-effectiveness of post-treatment follow-up examinations and secondary prevention of tuberculosis in a high-incidence setting – a model-based analysis. Lancet Global Health. 2020 Sep;8(9):e1223-e1233. PMID: 32827484
  6. Martinez L, Cords O, Acuna-Villaorduna C, Ahuja SD, Altet N, Augusto O, Baliashvili D, Basu S, Becerra M, Bonnet M, Boom WH, Borgdorff M, … Hesseling AC, … Lopez-Varela E, … Schaaf HS, Seddon JA, …, Sloot R, Andrews JR. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet 2020; 395(10228):973-984. PMID: 3219947.
  7. McArdle A, Keane D, Seddon JA, Bernatoniene J, Paton J, McMaster P, Williams A, Williams B, Kampmann B. Vitamin D deficiency is associated with tuberculosis disease in British children. Int J Tuberc and Lung Dis. 2020 Aug 1;24(8):782-788 PMID: 32912382.
  8. Mishra H, Reeve BW, Palmer Z, Caldwell J, Dolby T, Naidoo CC, Jackson JG, Schumacher SG, Denkinger CM, Diacon AH, van Helden PD, Marx FM, Warren RM, Theron G. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study. The Lancet Respiratory Medicine. 2020 Feb 14. PMID: 32066534.
  9. Morse R, Myburgh H, Archey A, Reubi D, Garcia-Prats AJ, Van der Zalm M, Hesseling AC, Seddon JA, Busakwe L, Jacobs S, Meyerson K, Wademan D, Nicholson T, Dooley K, Hoddinott G. Opportunities for mobile app-based adherence support for children with tuberculosis in South Africa. JMIR mHealth and uHealth. PMID: 33174850.
  10. Myburgh H, Peters RPH, Hurter T, Grobbelaar CJ, Hoddinott G. Transition to an in-facility electronic Tuberculosis register: Lessons from a South African pilot project. S Afr J HIV Med. 2020;21(1), a1025. PMID: 32158556.
  11. Ndjeka N, Hughes J, Reuter A, Conradie F, Enwerem M, Ferreira H, Ismail N, Kock Y, Master I, Meintjes, G, Padanilam X, Romero R, Schaaf HS, te Riele J, Maartens G. Implementing novel regimens for drug-resistant tuberculosis in South Africa: What can the world learn? Int J Tuberc Lung Dis.
  12. Ndjeka N, Conradie F, Meintjes G, Reuter A, Hughes J, Padanilam X, Ismail N, Kock Y, Master I, Romero R, Te Riele J. Responding to SARS-CoV-2 in South Africa: What can we learn from drug-resistant tuberculosis?. European Respiratory Journal. 2020 Jul 1;56(1). PMID: 32471936.
  13. Nash M, Perrin C, Seddon JA, Marais BJ, Starke J, Kitai I, Furin J, McKenna L. Unfinished business: access to paediatric formulations for the treatment of childhood tuberculosis. Lancet Child Adol Health. PMID: 33217352
  14. Nyberg HB, Draper HR, Garcia-Prats AJ, Thee S, Bekker A, Zar HJ, Hooker AC, Schaaf HS, McIlleron H, Hesseling AC, Denti P. Population pharmacokinetics and dosing of ethionamide in children with tuberculosis. Antimicrobial Agents and Chemotherapy. 2020 Feb 21;64(3). PMID: 31871093.
  15. Osman M, Welte A, Naidoo P, Loveday M, Hesseling AC. Limitations and potential bias in vital registration data and tuberculosis mortality reporting in South Africa. S Afr Med J. 2020 Jul;110(7):607-609. PMID: 32880331
  16. Osman, M., du Preez, K., Naidoo, P., Bock, P., Rabie, H., Dlamini, S. S., & Hesseling, A. C. (2020). Key changes in the public health response to TB and HIV in South Africa. Int J Tuberc Lung Dis, 24(8), 857-859. PMID: 32912394.
  17. Quaife M, Houben RMGJ, Allwood B, Cohen T, Coussens AK, Harries AD, van Kampen S, Marx FM, Sweeney S, Wallis RS, Menzies NA. Post-tuberculosis mortality and morbidity: valuing the hidden epidemic. The Lancet Respiratory Medicine. 2020 Apr;8(4):332-333. PMID: 32057300.
  18. Radtke KK, Hibma JE, Hesseling AC, Savic RM. Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children. Eur Respir J. 2020 Jul 23:2001756. [Online ahead of print.] PMID: 32703775.
  19. Reuter A, Seddon JA, Marais BJ, Furin J. Preventing Tuberculosis in Children: A Global Health Emergency. Paediatr Respir Rev 2020 Mar 5;S1526-0542(20)30023-3. [Online ahead of print]. PMID: 32253128.
  20. Richardson C, Redfern A, Sher-Locketz CL, Schubert PT, Schaaf HS. Fine needle aspiration biopsy of peripheral lymph nodes in children: practical experience in a tertiary hospital. J Trop Pediatr. 2020. PMID: 32621489.
  21. Sartoris G, Seddon JA, Rabie H, Nel ED, Schaaf HS. Abdominal Tuberculosis in Children: Challenges, Uncertainty, and Confusion. Journal of the Pediatric Infectious Diseases Society. 2020 Jan 7. PMID: 31909804.
  22. Sartoris G, Seddon JA, Rabie H, Nel ED, Losurdo G, Schaaf HS. Abdominal involvement in children with bacteriologically confirmed tuberculosis: a five-year experience from Cape Town, South Africa. Pediatr Infect Dis J. 2020 Jun 1. Online ahead of print. PMID: 32496408.
  23. Schaaf HS, Garcia-Prats AJ, Draper HR, Rautenbach C, Bosch C, Demers AM, Hesseling AC, Walters E. Trends in drug resistance in childhood tuberculosis in Cape Town, South Africa. Pediatr Infect Dis J. 2020 Jul;39(7):604-608. IDJ-219-840R2. PMID: 32520889.
  24. Schaaf HS, du Preez K, Kruger M, Solomons R, Taljaard JJ, Rabie H, Seddon JA, Cotton MF, Tebruegge M, Curtis N, Hesseling AC. Bacille Calmette-Guérin (BCG) in the context of the COVID-19 pandemic: responsible stewardship needed. In J Tuberc Lung Tuberc Lung Dis. 2020 Jul 1;24(7):732-734. PMID: 32718410.
  25. Seddon JA, Johnson S, Palmer M, van der Zalm MM, Lopez-Varela E, Hughes J, Schaaf HS. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Rev Respir Med. 2020: 1-17
  26. Shanaube K, Macleod D, Chaila MJ, Mackworth-Young C, Hoddinott G, Schaap A, Floyd S, Bock P, Hayes R, Fidler S, Ayles H. HIV Care cascade among adolescents in a “Test and Treat” community-based intervention: HPTN 071 (PopART) for Youth Study. Journal of Adolescent Health. 2020 Oct 12. PMID: 33122339.
  27. Sloot R, Shanaube K, Claassens M, Telisinghe L, Schaap A, Godfrey-Faussett P, Ayles H, Floyd S. Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa. BMC infectious diseases. 2020 Dec;20(1):1-9. PMID: 33059620.
  28. Sloot R, Glenshaw MT, Van Niekerk M, Meehan SA. Rapid point-of-care CD4 testing at mobile units and linkage to HIV care: an evaluation of community-based mobile HIV testing services in South Africa. BMC Public Health. 2020 Dec;20:1-9. PMID: 32306930
  29. Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, Dodd PJ, Houben RM, Denholm JT, Sawyer SM, Kranzer K. Adolescent tuberculosis. Lancet Child Adolesc Health. 2020; 4: 68-79
  30. Srivastava S, van Zyl J, Cirrincione K, Martin KR, Deshpande D, Thomas T, Alffenaar J, Seddon JA, Gumbo T. Evaluation of ceftriaxone plus avibactam in an intracellular hollow fiber model of tuberculosis: implications for the treatment of disseminated and meningeal tuberculosis in children. Ped Infect Dis J 2020. PMID: 32773662.
  31. Stangl AL, Pliakas T, Mainga T, Steinhaus M, Mubekapi-Musadaidzwa C, Viljoen L, Dunbar R, Schaap A, Floyd S, Mandla N, Bond V, Hoddinott G, Fidler S, Hayes R, Ayles H, Bock P, Donnell D, Hargreaves JR. The effect of universal testing and treatment on HIV stigma in 21 communities in Zambia and South Africa. AIDS. 2020;33. PMID: 32773484.
  32. Tucker EW, Marais S, Seddon JA, van Crevel R, Ganiem AR, Ruslami R, Zhang W, Sun F, Zhou X, Solomons RS, Cresswell FV. International survey reveals opportunities to improve tuberculous meningitis management and the need for standardized guidelines. In Open forum infectious diseases 2020 Nov (Vol. 7, No. 11, p. ofaa445). US: Oxford University Press. PMID: 33209947
  33. van der Zalm MM, Lishman J, Verhagen LM, Redfern A, Smit L, Barday M, Ruttens D, van Jaarsveld S, Itana J, Schrueder N, Van Schalkwyk M, Itana J, Schrueder N, van Schalkwyk M, Parker N, Appel I, Fourie B, Claassen M, Workman JJ, Goussard P, Van Zyl G, Rabie H. Clinical experience with SARS CoV-2 related illness in children-hospital experience in Cape Town, South Africa. Clinical Infectious Diseases. 2020 Nov 10. PMID: 33170927
  34. van der Zalm MM, Walters E, Claassen M, Palmer M, Seddon JA, Demers AM, Shaw ML, McCollum ED, van Zyl GU, Hesseling AC. High burden of viral respiratory co-infections in a cohort of children with suspected pulmonary tuberculosis. BMC Infectious Diseases. 2020 Dec;20(1):1-9. PMID: 33276721.
  35. Van Toorn R, Solomons R, Seddon JA, Schoeman J. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clin Infect Dis. 020 Dec 6;ciaa1826. PMID: 33283220.
  36. Viljoen, L., Myburgh, H., Reynolds, L. on behalf of the HPTN 071 PopART team. Managing comorbidities and public/private dichotomies in the HPTN071/PopART trial. Medical Anthropology: Cross-Cultural Studies in Health and Illness. 2020 Oct 1;1-14. doi: 10.1080/01459740.2020.1820501. [Online ahead of print] PMID: 33000972.
  37. Viljoen, L., Bond, V.A., Reynolds, L.J., Mubekapi‐Musadaidzwa, C., Baloyi, D., Ndubani, R., Stangl, A., Seeley, J., Pliakas, T., Bock, P., Fidler, S. Hayes., Ayles, H., Hargreaves, J. R., Hoddinott, G. and on behalf of the HPTN 071 (PopART) team. 2020. Universal HIV testing and treatment and HIV stigma reduction: a comparative thematic analysis of qualitative data from the HPTN 071 (PopART) trial in South Africa and Zambia. Sociology of Health & Illness. (October, 21):1467-9566.13208. DOI: 10.1111/1467-9566.13208. PMID: 33085116
  38. Wademan DT, Busakwe L, Nicholson TJ, van der Zalm M, Palmer M, Workman J, Turkova A, Crook AM, Thomason J, Gibb DM, Seeley J, Hesseling A, Hoddinott G. Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial. Int J Tuberc Lung Dis. 2019 Dec

1;23(12):1263-1268. doi: 10.5588/ijtld.19.0115. PMID: 31931909.

  1. Winckler, JL, Draper HR, Schaaf HS, van der Laan LE, Hesseling AC, Garcia-Prats AJ. Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB. International Journal of Tuberculosis and Lung Disease 2020; 24(12):1316-1318.
  2. Yuen CM, Seddon JA, Keshavjee S, Dodd PJ. Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study. The Lancet Global Health. 2020 May 1;8(5):e672-80. PMID: 32353315.
  3. Zimri K, Casper R, Hoddinott G, Schaaf HS, Garcia-Prats AJ, Rose PC, Hesseling AC, and Viljoen L. 2020. A novel approach for eliciting adolescent MDR-TB treatment tolerability: qualitative data from South Africa. The International Journal of Tuberculosis and Lung Disease, 24(1), pp.43-47. doi: 10.5588/ijtld.19.0207. PMID: 32005306.

 

Research Reports

  1. Researchers at the DTTC (Megan Palmer, Karen du Preez, James Seddon, Marieke van der Zalm and Anneke Hesseling) contributed to the following research report: Van der Berg, S & Spaull, N. 2020. Counting the Cost: COVID-19 school closures in South Africa & its impacts on children. Research on Socioeconomic Policy (RESEP). Stellenbosch University. Stellenbosch.
  2. Bock, P. Primary results of the HPTN 071 Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART) Trial. Research Newsletter: Public Health Matters in the Western Cape, South Africa. Issue 13. January 2020, page 9.

 

Book Chapters

 

  1. Viljoen L, Myburgh H, Reynolds, LJ. A family affair: Managing comorbidities and the spaces between the private and the public in Connected Lives: Families, Households, Health and Care in Contemporary South Africa (eds. Nolwazi Mkhwanazi and Lenore Manderson), Cape Town, HSRC Press.